Candidemia in the Intensive Care Unit

Oleg Epelbaum, Rachel Chasan

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations


Candidemia presents several challenges to the intensive care unit (ICU) community. Recognition and treatment of this infection is frequently delayed, with dramatic clinical deterioration and death often preceding the detection of Candida in blood cultures. Identification of individual patients at the highest risk for developing candidemia remains an imperfect science; the role of antifungal therapy before culture diagnosis is yet to be fully defined in the ICU. The absence of well-established molecular techniques for early detection of candidemia hinders efforts to reduce the heavy clinical and economic impact of this infection. Echinocandins are the recommended antifungal drug class for the treatment of ICU candidemia.

Original languageEnglish
Pages (from-to)493-509
Number of pages17
JournalClinics in Chest Medicine
Issue number3
StatePublished - Sep 2017


  • Candida
  • Candidemia
  • Critical care
  • Fungal infection
  • Intensive care unit
  • Invasive candidiasis


Dive into the research topics of 'Candidemia in the Intensive Care Unit'. Together they form a unique fingerprint.

Cite this